FDA Inspection
Gland Pharma LimitedGland Pharma Limited – FDA Inspection, Feb 25, 2025
Record Details
This FDA Inspection record concerns Gland Pharma Limited, with an inspection on February 25, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 2972bd2d-c5e8-4a15-963c-a84d5805c9d3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1261860
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.42(c)(10)(v)Cleaning System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gland Pharma Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 29, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gland Pharma Limited
- FDA Inspection 1245692 - 2024-05-24
- FDA Inspection 1199204 - 2023-01-27
- FDA Inspection 1052383 - 2018-04-20
- FDA Inspection 951916 - 2015-10-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.